Equillium announces three abstracts accepted for presentation at the 104th annual meeting of the american association of immunologists

Presentations highlight the pathogenic role of the cd6-alcam pathway, the immunologic impact of modulating this pathway with itolizumab, and pharmacodynamic assays to monitor this in patients presentations highlight the pathogenic role of the cd6-alcam pathway, the immunologic impact of modulating this pathway with itolizumab, and pharmacodynamic assays to monitor this in patients
EQ Ratings Summary
EQ Quant Ranking